Direct Healthcare Professional Communication (DHPC) on Berlthyrox® (levothyroxine sodium): new composition and new trade name L-Thyroxine BC® - Information and control of patients during the changeover
2022.01.10
Active substance: levothyroxine sodium
Berlin-Chemie AG informs in coordination with the Federal Institute for Drugs and Medical Devices (BfArM) that a new composition of Berlthyrox® will be available from mid-January 2022 under the new trade name L-Thyroxin BC® and with a new package design. The new composition offers improved stability of the active ingredient levothyroxine sodium throughout the shelf life of the medicinal product.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN